Human 3β-hydroxysteroid dehydrogenase: genes and phenotypes

in Journal of Molecular Endocrinology
Authors:
R G Sutcliffe
Search for other papers by R G Sutcliffe in
Current site
Google Scholar
PubMed
Close
,
A J Russell
Search for other papers by A J Russell in
Current site
Google Scholar
PubMed
Close
,
C R W Edwards
Search for other papers by C R W Edwards in
Current site
Google Scholar
PubMed
Close
, and
A M Wallace
Search for other papers by A M Wallace in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $1.00
USD  $1.00

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $1.00
USD  $1.00

USD  $1.00
USD  $1.00

USD  $1.00
USD  $1.00

USD  $1.00
USD  $1.00

USD  $1.00
USD  $1.00

Understanding of the principal pathways of steroid hormone biosynthesis was established over two decades ago through advances in steroid radioisotopic and chromatographic techniques. When the enzymes of individual pathways could be examined in more detail, the dissection of the complex pattern of enzyme activities began. At many points, separate pathways employ precisely the same enzyme for equivalent catalytic steps, e.g. for 21-hydroxylase, 11 β-hydroxylase, aromatase and several dehydrogenases (Orth et al. 1992). A further economy was found for 17α-hydroxylase and 17,20-lyase activities, which co-purify with the same P450c17 polypeptide. This enzyme was later cloned and expressed in tissue culture cells, revealing that, contrary to the enzyme in rat, human and cattle, 17α-hydroxylase cannot convert 17α-hydroxyprogesterone to androstenedione (Bradshaw et al. 1987, Fevold et al. 1989). Further complexity emerged with the existence of multiple tissue-specific forms of 5α-reductase (Wilson et al. 1993), and 3β-, 11β- and 17β-hydroxysteroid dehydrogenases, most of which

 

  • Collapse
  • Expand